🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

Back

Nimesh Pinnamaneni

 • 

Helixworks Technologies • 2d

From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power

See More
Anonymous

Anonymous 4

Hey I am on Medial • 2d

As someone who actually used both Cepheid and Truenat systems during COVID (I work in hospital administration), there are significant differences. Cepheid is more user-friendly with fully integrated cartridges but costs 3-4x more per test. Truenat requires more manual steps but is much more cost-effective. In wealthy countries, Cepheid wins easily. In resource-limited settings, Truenat has a massive advantage. The question for investors is where the growth will come from. If Molbio stays focused on emerging markets, they could build a sustainable business. If they try to compete head-on with Cepheid in developed markets, they'll likely fail. Their valuation assumes they'll succeed everywhere, which is unrealistic.

1 replies3 likes
Replies (1)

More like this

Recommendations from Medial

Image Description
Image Description

Nimesh Pinnamaneni

 • 

Helixworks Technologies • 2d

From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power

See More
10 replies40 likes
15
Image Description

Armaan Nath

Founder's Office | P... • 5m

Today marks a very important day, I got rejected for giving an interview because currently my location is in tier-2 city.😂🤌🏻 Man come on! That's unrealistic!

4 replies6 likes
Image Description
Image Description

Mohit Mittal_KMC

Hey I am on Medial • 1m

Do a startup making incense sticks/cones from waste flowers would work in urban Markets? Considering the end product is 3-5x more expensive than the established incense stick manufacturers ?

2 replies4 likes
Image Description

Chamarti Sreekar

Passionate about Pos... • 28d

The Future is Being Built Right Now – And This is MASSIVE $20 billion. That’s the valuation Safe Superintelligence is now chasing—a 4X jump in just a few months. This isn’t just another AI startup raising capital. This is the birth of something monu

See More
1 replies19 likes
Anonymous

Anonymous

Hey I am on Medial • 9m

Secrets and leadership of the biggest consumer banks. DImon Is truly a giant and powerhouse. Who can make, break, follow on and destroy trends in financial markets. Even though his image is of a family man. His power in the financial markets is unm

See More
0 replies4 likes
Image Description

Mohit Kumar

Entrepreneur | App &... • 10m

How is Indian AR VR Markets ? Do you know any startups who are doing wonderful in VR Market?

1 replies2 likes
Image Description

Mahendra Lochhab

Content creator • 8m

India's insurance market is the 10th largest in the world and the second largest in emerging markets, with an estimated 1.9% market share.

1 replies3 likes
Anonymous
Image Description
Image Description

Anonymous

Hey I am on Medial • 12m

Are duopolies inevitable in certain markets and industries ? Is this better than 4 to 5 firms competing with each other ?

4 replies8 likes

Nimesh Pinnamaneni

 • 

Helixworks Technologies • 7d

Why qPCR & Phenotypic Testing Must Be Displaced? – Part III This is the third part of a deep dive into why qPCR & phenotypic testing need to be replaced. In Part I, I covered the limitations of current diagnostics & why incremental improvements aren

See More
0 replies2 likes

Kimiko

Posts about startup ... • 18d

A stock broker is very important aspect when considering your trading journey. Here is a deep insight on which brokers are leading in Indian Financial Markets

0 replies26 likes
1

Download the medial app to read full posts, comements and news.